Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2 - Concepedia

Concepedia

Publication | Open Access

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

DOI Full Paper Access

1.7K

Citations

26

References

2004

Year

Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, Ronald B. Natale, Vincent A. Miller, Christian Manegold, Giorgio V. Scagliotti, Rafael Rosell, Ira A. Oliff, James A. Reeves,

Journal of Clinical Oncology

Abstract

Gefitinib showed no added benefit in survival, TTP, or RR compared with standard chemotherapy alone. This large, placebo-controlled trial confirmed the favorable gefitinib safety profile observed in phase I and II monotherapy trials.

References

	Year	Citations

Page 1